M&A activity held strong as Tyber Medical, Intech, and Resolve Surgical Technologies announced they will merge into a combined entity. Montagu is overseeing the transaction as it acquires Tyber Medical, which will combine with Montagu’s existing investments in Resolve. The combined entity will offer a mix of proprietary market-cleared technologies, and development and manufacturing scale.

Two technologies were announced in surgery milestones this week. Accufix Surgical announced the 200^thprocedure using its Accu-Joint Hemi implant. This addresses the limitations of traditional joint implants and fusion surgery and allows for bone resurfacing without significant resection.

Orthobond also delivered its 1st Ostaguard Antibacterial Coated Implants for surgery. This non-eluting coating actively kills bacteria that contaminate the surface of a medical device in the operating room and comes eight months after it received FDA de novo clearance. 

Also, this past week, icotec earned its U.S. Food and Drug Administration (FDA) clearance to use its BlackArmor implants to treat de novo spinal infections. The FDA also awarded BlackArmor with a breakthrough status. icotec is the first, only company in the U.S. with 510(k) clearance to stabilize the spine in de novo spinal infections, including discitis, osteomyelitis, pyogenic infection of the intervertebral disc, and other spondylopathies.

1. Tyber Medical, Intech, and Resolve Surgical Technologies to Merge
2. Accufix Surgical Achieves 200th Accu-Joint Procedure
3. 2025 Orthopedic Device Companies M&A Roundup
4. icotec’s BlackArmor Implants Win FDA Nod for Spinal Infection
5. Orthobond Delivers 1st Ostaguard Antibacterial Coated Implants for Surgery